Granules India intimates of successful USFDA inspection of Gagillapur facility

Image
Capital Market
Last Updated : Oct 17 2016 | 9:47 AM IST

Located at Hyderabad, Telangana

Granules India announced that Company's Gagillapur facility located at Hyderabad, Telangana, India has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Oct 17 2016 | 9:24 AM IST

Next Story